Skip to main content
Clinical Trials/NCT06119464
NCT06119464Active, not recruitingNot Applicable

Re-Purposing the Ordering of 'Routine' Laboratory Tests in Hospitalized Medical Patients (RePORT Study)

University of Calgary1 site in 1 country251,817 target enrollmentStarted: January 2, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
251,817
Locations
1
Primary Endpoint
Number of routine laboratory tests ordered per patient-day in the intervention versus control periods

Study Overview

Brief Summary

Laboratory test overuse occurs when tests are ordered repetitively, without due consideration of impact on clinical status. Repetitive inpatient lab testing often provides limited value for patient outcomes while increasing healthcare costs, patient discomfort, and unnecessary transfusions and prolonging hospitalizations. The research study aims to reduce laboratory test overuse in hospitals through implementation of a comprehensive, multi-disciplinary, and multi-faceted intervention bundle that includes audit and feedback reports, clinician education, clinical decision support tool, and patient infographics across 14 hospitals in Alberta.

Detailed Description

Background: Laboratory and Pathology testing contributes to rising health care expenditure. A relatively large percentage (up to 42%) of laboratory testing can be considered wasteful. Redundant testing alone has been estimated to waste up to 5 billion dollars annually in the United States of America. Laboratory over-utilization leads to false positives that promotes further inappropriate testing and procedures, interruption of normal sleep pattern of inpatients, as well as iatrogenic anemia and pain. A Canadian study showed significant hemoglobin reductions as a result of phlebotomy. Studies support the safe reduction of repetitive laboratory testing without negative effects on adverse events, readmission rates, critical care utilization, or mortality.

The aim of this research study is the following:

  1. To implement a multimodal intervention bundle containing healthcare provider and patient engagement tools for hospitalized medical inpatients in 14 hospitals across the province of Alberta in Canada using a cluster randomized stepped-wedge design
  2. To evaluate the impact of the intervention bundle on laboratory test utilization of six target laboratory tests (complete blood count, electrolytes, creatinine, urea, partial thromboplastin time, and international normalized ratio), costs, and patient safety outcomes.

This intervention bundle will be implemented across all the adult hospital sites in Alberta starting January 2023 and evaluated until October 2024.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •all participants (patients and healthcare providers) within enrolled adult hospitals in Alberta of medical and hospitalist units during study period

Exclusion Criteria

  • •outside of the above-mentioned province
  • •hospitals not enrolled
  • •non-medical units (eg. ICU, surgical, pediatric, obstetrical units)

Arms & Interventions

Unexposed to intervention (control period)

No Intervention

This is the time period of the study where hospital clusters are not receiving the intervention

Exposed to intervention (intervention period)

Experimental

This is the time period of the study where hospital clusters are receiving the multimodal intervention.

Intervention: Multimodal Intervention: Education (Other)

Exposed to intervention (intervention period)

Experimental

This is the time period of the study where hospital clusters are receiving the multimodal intervention.

Intervention: Multimodal Intervention: Audit and Feedback (Other)

Exposed to intervention (intervention period)

Experimental

This is the time period of the study where hospital clusters are receiving the multimodal intervention.

Intervention: Multimodal Intervention: Patient Engagement (Other)

Exposed to intervention (intervention period)

Experimental

This is the time period of the study where hospital clusters are receiving the multimodal intervention.

Intervention: Multimodal Intervention: System Changes (Other)

Outcomes

Primary Outcomes

Number of routine laboratory tests ordered per patient-day in the intervention versus control periods

Time Frame: 1 year 9 months

Number of the six target laboratory tests (complete blood count, electrolytes, creatinine, urea, international normalized ratio and partial thromboplastin time) ordered per patient-day

Secondary Outcomes

  • In-patient and 30-day patient mortality over study period(30 days post discharge)
  • 30-day post discharge readmission rate(30 days post discharge)
  • Length of stay(1 year 9 months)
  • Proportion of critically abnormal test results(1 year 9 months)
  • Transfer to Intensive Care Unit(1 year 9 months)
  • Costs associated with routine and all common laboratory test ordered(1 year 9 months)
  • Proportion of hospital patient lab-free days(1 year 9 months)
  • Number of all common laboratory tests(1 year 9 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anshula Ambasta

Clinical Assistant Professor

University of Calgary

Study Sites (1)

Loading locations...

Similar Trials